Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robbert J de Winter

Showing results (421-430 of 467) with videos related to

Pageof 47
Sort By:
Thrombosis and Haemostasis|December 8, 2007
The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventionsDouwe Pons, Pascalle S Monraats, Moniek P M de Maat, et al.
Journal of the American Heart Association|November 10, 2021
Cardiovascular Morbidity and Mortality in Adult Patients With Repaired Aortic CoarctationTimion A Meijs, Savine C S Minderhoud, Steven A Muller, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 6, 2025
Impact of lesion preparation and stent optimisation on lesion-oriented events in PCI with drug-eluting stents: 5-year results from the AIDA trialMick P L Renkens, Maik J D Grundeken, Laura S M Kerkmeijer, et al.
Heart (British Cardiac Society)|January 6, 2022
Hypertensive response to exercise in adult patients with repaired aortic coarctationTimion A Meijs, Steven A Muller, Savine C S Minderhoud, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 24, 2018
The incidence and relevance of site-reported vs. patient-reported angina: insights from the ABSORB II randomized trial comparing Absorb everolimus-eluting bioresorbable scaffold with XIENCE everolimus-eluting metallic stentMaik J Grundeken, Roseann M White, John B Hernandez, et al.
Heart (British Cardiac Society)|April 15, 2014
Impact of hyperaemic microvascular resistance on fractional flow reserve measurements in patients with stable coronary artery disease: insights from combined stenosis and microvascular resistance assessmentTim P van de Hoef, Froukje Nolte, Mauro EchavarrÍa-Pinto, et al.
Plos One|July 21, 2020
Pre-PCI versus immediate post-PCI Impella initiation in acute myocardial infarction complicated by cardiogenic shockVeemal V Hemradj, Mina Karami, Krischan D Sjauw, et al.
European Heart Journal. Acute Cardiovascular Care|November 8, 2018
Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experienceDagmar M Ouweneel, Justin de Brabander, Mina Karami, et al.
The American Journal of Cardiology|October 16, 2020
Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS)Hideyuki Kawashima, Mariusz Tomaniak, Masafumi Ono, et al.
Pharmacogenetics and Genomics|September 27, 2006
Inflammation and apoptosis genes and the risk of restenosis after percutaneous coronary interventionPascalle S Monraats, Florentine de Vries, Laura W de Jong, et al.
Pageof 47

Showing results (421-430 of 467) with videos related to

Sort By:
Pageof 47
Thrombosis and Haemostasis|December 8, 2007
The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventionsDouwe Pons, Pascalle S Monraats, Moniek P M de Maat, et al.
Journal of the American Heart Association|November 10, 2021
Cardiovascular Morbidity and Mortality in Adult Patients With Repaired Aortic CoarctationTimion A Meijs, Savine C S Minderhoud, Steven A Muller, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 6, 2025
Impact of lesion preparation and stent optimisation on lesion-oriented events in PCI with drug-eluting stents: 5-year results from the AIDA trialMick P L Renkens, Maik J D Grundeken, Laura S M Kerkmeijer, et al.
Heart (British Cardiac Society)|January 6, 2022
Hypertensive response to exercise in adult patients with repaired aortic coarctationTimion A Meijs, Steven A Muller, Savine C S Minderhoud, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 24, 2018
The incidence and relevance of site-reported vs. patient-reported angina: insights from the ABSORB II randomized trial comparing Absorb everolimus-eluting bioresorbable scaffold with XIENCE everolimus-eluting metallic stentMaik J Grundeken, Roseann M White, John B Hernandez, et al.
Heart (British Cardiac Society)|April 15, 2014
Impact of hyperaemic microvascular resistance on fractional flow reserve measurements in patients with stable coronary artery disease: insights from combined stenosis and microvascular resistance assessmentTim P van de Hoef, Froukje Nolte, Mauro EchavarrÍa-Pinto, et al.
Plos One|July 21, 2020
Pre-PCI versus immediate post-PCI Impella initiation in acute myocardial infarction complicated by cardiogenic shockVeemal V Hemradj, Mina Karami, Krischan D Sjauw, et al.
European Heart Journal. Acute Cardiovascular Care|November 8, 2018
Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experienceDagmar M Ouweneel, Justin de Brabander, Mina Karami, et al.
The American Journal of Cardiology|October 16, 2020
Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS)Hideyuki Kawashima, Mariusz Tomaniak, Masafumi Ono, et al.
Pharmacogenetics and Genomics|September 27, 2006
Inflammation and apoptosis genes and the risk of restenosis after percutaneous coronary interventionPascalle S Monraats, Florentine de Vries, Laura W de Jong, et al.
Pageof 47